Effects of selective cholinergic antagonists and alpha,beta-methylene ATP on guinea-pig urinary bladder contractions in vivo following pelvic nerve stimulation

Journal of Autonomic Pharmacology
J S Peterson, L Noronha-Blob


1. An in vivo preparation measuring functional detrusor muscle strength in terms of intravesical bladder pressure (Pves) following in situ pelvic nerve stimulation has been developed in urethane-anaesthetized guinea pigs. 2. The increase in bladder pressure following pelvic nerve stimulation was abolished by topical lidocaine or tetrodotoxin, suggesting a neurogenic origin for the in vivo contractile response. 3. Cholinergic antagonists (i.v.) decreased the amplitude of the peak pressure response by about 50% at both high (30 Hz) and low (5 Hz) stimulation rates, with a rank order of potency of atropine greater than propantheline greater than oxybutynin greater than hexahydrosiladifenidol greater than pirenzepine greater than methoctramine. 4. The P2 purine receptor antagonist, alpha,beta-methylene ATP (i.v.), antagonized pelvic nerve-stimulated bladder contractions differentially at 5 and 30 Hz. At low frequencies, alpha, beta-methylene ATP was both more potent (2.5-fold) and more efficacious (-77 compared to -55% delta) than at 30 Hz. Atropine and alpha,beta-methylene ATP together completely inhibited the contractile response. 5. Together, the findings indicate that in guinea pigs, urinary bladder contractions induced by pelv...Continue Reading


Mar 1, 1979·Acta Pharmacologica Et Toxicologica·C Sjögren, K E Andersson
May 1, 1989·Journal of Pharmacological Methods·J S PetersonL Noronha-Blob
Dec 1, 1987·Journal of Autonomic Pharmacology·C A MaggiP Santicioli
Sep 13, 1988·European Journal of Pharmacology·L Noronha-BlobW J Kinnier
Sep 1, 1988·Naunyn-Schmiedeberg's Archives of Pharmacology·J WessG Lambrecht
Jan 1, 1988·Pharmacology & Therapeutics·F Mitchelson
Apr 1, 1986·The Journal of Urology·R M LevinA J Wein
Oct 1, 1970·The Journal of Physiology·N Ambache, M A Zar
Sep 1, 1967·European Journal of Pharmacology·P Mantegazza, K M Naimzada
Dec 1, 1984·Acta Physiologica Scandinavica·M Hammarström, N O Sjöstrand
Mar 4, 1983·European Journal of Pharmacology·D P WestfallJ P O'Donnell
Aug 1, 1954·The Journal of Urology·E H INGERSOLLE S HEGRE

❮ Previous
Next ❯


Jan 1, 1996·Neurourology and Urodynamics·T Watanabe, C E Constantinou
Dec 15, 2000·Progress in Pediatric Cardiology·S LatifiJ L Blumer
Nov 23, 2013·Purinergic Signalling·Geoffrey Burnstock
Jan 25, 2007·Basic & Clinical Pharmacology & Toxicology·Daniel GiglioGunnar Tobin
Aug 21, 2019·British Journal of Pharmacology·Carly J McCarthyChristopher H Fry
Dec 12, 2002·Scandinavian Journal of Urology and Nephrology. Supplementum·A L DalmoseJ C Djurhuus
May 3, 2019·American Journal of Physiology. Cell Physiology·Zhihui FongGerard P Sergeant
Aug 3, 2021·Autonomic Neuroscience : Basic & Clinical·Charles Kennedy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.